Literature DB >> 26201799

Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy.

Ali Muhi1, Tomoaki Ichikawa2, Utaroh Motosugi1, Katsuhiro Sano1, Zareen Fatima1, Masanori Matsuda3, Hideki Fujii3, Nobuyuki Enomoto4, Tsutomu Araki1.   

Abstract

PURPOSE: The effectiveness of imaging (including apparent diffusion coefficient [ADC] of diffusion-weighted magnetic resonance imaging [DWI]) and laboratory variables for predicting early tumor recurrence and overall survival after surgery in hepatocellular carcinoma (HCC) patients are analyzed.
METHODS: The present study included 116 consecutive patients with HCC who underwent partial hepatectomy. Patients were classified into two groups: patients with and without early recurrence (<1 year). Preoperative imaging variables (tumor number, size, shape, capsule, ADC, and venous invasion) and laboratory variables were evaluated to predict early recurrence using univariate and multivariate analyses. Overall survival was calculated using the Kaplan-Meier method.
RESULTS: Twenty patients (17 %) developed early recurrence after surgery. Multivariate logistic regression analysis showed that tumor ADC (p = 0.0002), aspartate aminotransferase (p = 0.0121), and serum prothrombin time activity percentage (p = 0.0082) were statistically significant for predicting early recurrence. The optimal ADC cutoff value for predicting early recurrence obtained from receiver operating characteristic analysis was ≤0.898 × 10(-3) mm(2)/s. In patients with ADC ≤0.898 × 10(-3) mm(2)/s, the 3- and 5-year survival rates (77 and 56 %, respectively) were significantly decreased compared with those in patients with ADC >0.898 × 10(-3) mm(2)/s (97 and 97 %, respectively; p = 0.0015).
CONCLUSIONS: Low tumor ADC value by DWI was a risk factor for early postoperative HCC recurrence and was associated with lower patient survival rates.

Entities:  

Keywords:  Apparent diffusion coefficient; Liver; Magnetic resonance imaging

Year:  2012        PMID: 26201799     DOI: 10.1007/s12072-012-9383-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  27 in total

1.  Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.

Authors:  David Nunes; Catherine Fleming; Gwynneth Offner; Donald Craven; Oren Fix; Timothy Heeren; Margaret J Koziel; Camilla Graham; Sheila Tumilty; Paul Skolnik; Sherri Stuver; C Robert Horsburgh; Deborah Cotton
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

2.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

Review 3.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

4.  Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Jae Hyuk Lee; Yang Seok Koh; Chol Kyoon Cho; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

5.  Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.

Authors:  Gi-Hong Choi; Dong-Hyun Kim; Chang-Moo Kang; Kyung-Sik Kim; Jin-Sub Choi; Woo-Jung Lee; Byong-Ro Kim
Journal:  Ann Surg Oncol       Date:  2007-11-15       Impact factor: 5.344

6.  Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.

Authors:  Junji Yamamoto; Tomoo Kosuge; Akio Saiura; Yoshihiro Sakamoto; Kazuaki Shimada; Tsuyoshi Sano; Tadatoshi Takayama; Yasuhiko Sugawara; Toshiharu Yamaguchi; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Jpn J Clin Oncol       Date:  2007-04       Impact factor: 3.019

7.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

8.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.

Authors:  Honsoul Kim; Mi-Suk Park; Young Nyun Park; Hyunki Kim; Kyung Sik Kim; Jin Sub Choi; Sang Hoon Ahn; Kwang-Hyub Han; Myeong-Jin Kim; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more
  3 in total

1.  Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.

Authors:  Hong Wei; Hanyu Jiang; Yun Qin; Yuanan Wu; Jeong Min Lee; Fang Yuan; Tianying Zheng; Ting Duan; Zhen Zhang; Yali Qu; Jie Chen; Yuntian Chen; Zheng Ye; Shan Yao; Lin Zhang; Ting Yang; Bin Song
Journal:  Eur Radiol       Date:  2022-05-13       Impact factor: 5.315

2.  MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy.

Authors:  Lina Zhang; Jingbiao Chen; Hang Jiang; Dailin Rong; Ning Guo; Hao Yang; Jie Zhu; Bing Hu; Bingjun He; Meng Yin; Sudhakar K Venkatesh; Richard L Ehman; Jin Wang
Journal:  Eur J Radiol       Date:  2022-05-05       Impact factor: 4.531

Review 3.  Imaging of HCC-Current State of the Art.

Authors:  Christina Schraml; Sascha Kaufmann; Hansjoerg Rempp; Roland Syha; Dominik Ketelsen; Mike Notohamiprodjo; Konstantin Nikolaou
Journal:  Diagnostics (Basel)       Date:  2015-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.